Non-bacterial thrombotic endocarditis laboratory findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Non-bacterial thrombotic endocarditis}} {{CMG}}; {{AE}}{{Homa}} ==Overview== An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diag...")
 
 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Non-bacterial thrombotic endocarditis}}
{{Non-bacterial thrombotic endocarditis}}
{{CMG}}; {{AE}}{{Homa}}
{{CMG}}; {{AE}}{{Aisha}}


==Overview==
==Overview==
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
There are no specific diagnostic laboratory findings associated with non-bacterial thrombotic endocarditis. Tests are usually conducted to detect the underlying cause of NBTE and differentiate it from infective endocarditis;.
 
OR
 
Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
 
OR
 
[Test] is usually normal for patients with [disease name].
 
OR
 
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 
OR
 
There are no diagnostic laboratory findings associated with [disease name].


==Laboratory Findings==
==Laboratory Findings==


There are no diagnostic laboratory findings associated with [disease name].
*There are no specific [[diagnostic]] laboratory findings associated with [[non-bacterial thrombotic endocarditis]].
 
*The following laboratory tests are usually conducted to detect the underlying cause of NBTE and differentiate it from [[infective endocarditis]];
OR
===Hematological and coagulation studies ===
 
*[[Complete blood count|CBC]]: may show [[neutrophilia]] and [[anemia]]
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
*[[Prothrombin time]], [[partial thromboplastin time]], [[fibrinogen]], [[thrombin time]], [[D-dimer|D-dimers]], and cross-linked [[Fibrin degradation product|fibrin degradation products]] (abnormal values may depict [[Disseminated intravascular coagulation|DIC]]).
 
===Blood cultures===
OR
*Multiple [[Blood culture|blood cultures]] (minimum to 3 blood cultures prior to antibiotic use) to rule out [[infective endocarditis]] and other infectious etiologies<ref name="urlLibman-Sacks Endocarditis Clinical Presentation: History, Physical Examination">{{cite web |url=https://emedicine.medscape.com/article/155230-clinical |title=Libman-Sacks Endocarditis Clinical Presentation: History, Physical Examination |format= |work= |accessdate=}}</ref>.
 
===Immunological assays<ref name="pmid8608627">{{cite journal |vauthors=Hojnik M, George J, Ziporen L, Shoenfeld Y |title=Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome |journal=Circulation |volume=93 |issue=8 |pages=1579–87 |date=April 1996 |pmid=8608627 |doi=10.1161/01.cir.93.8.1579 |url=}}</ref><ref name="pmid15507284">{{cite journal |vauthors=Cervera R |title=Coronary and valvular syndromes and antiphospholipid antibodies |journal=Thromb. Res. |volume=114 |issue=5-6 |pages=501–7 |date=2004 |pmid=15507284 |doi=10.1016/j.thromres.2004.06.026 |url=}}</ref>===
[Test] is usually normal among patients with [disease name].
*[[Antinuclear antibodies]] ([[SLE]] [[Screening test|screening]])
 
*[[Anti-dsDNA antbodies|Anti-dsDNA antibodies]] ([[SLE]] [[Confirmatory factor analysis|confirmation]] and to [[Monitor role|monitor]] the progress of [[disease]] and [[lupus nephritis]])
OR
* Anti-Smith [[antibodies]]
 
*Anti-RNP
Laboratory findings consistent with the diagnosis of [disease name] include:
*[[Antiphospholipid antibodies]]
*[Abnormal test 1]
*[[Anticardiolipin antibodies]] ([[Association (statistics)|associated]] with an increased [[RiskMetrics|risk]] of [[cardiac]] [[abnormalities]])
*[Abnormal test 2]
*Anti-Ro/SSA
*[Abnormal test 3]
*Anti-La/SSB
 
*[[False-positive test result|False-positive]] [[serology]] in the form of [[Venereal disease research laboratory (VDRL) test|VDRL]] is also common in [[SLE]]
OR
===Inflammatory markers===
 
The following inflammatory markers are often elevated
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
*[[C-reactive protein]]
*[[Erythrocyte sedimentation rate]] (ESR)
===Polymerase chain reaction (PCR)===
*[[PCR]] is a rapid and reliable method to detect the culture-negative endocarditis by fastidious organisms<ref name="pmid15145855">{{cite journal |vauthors=Prendergast BD |title=Diagnostic criteria and problems in infective endocarditis |journal=Heart |volume=90 |issue=6 |pages=611–3 |date=June 2004 |pmid=15145855 |pmc=1768277 |doi=10.1136/hrt.2003.029850 |url=}}</ref><ref name="pmid11669225">{{cite journal |vauthors=Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, Raoult D, Earle J, Hone R, Murphy P |title=Molecular diagnosis of infective endocarditis--a new Duke's criterion |journal=Scand. J. Infect. Dis. |volume=33 |issue=9 |pages=673–80 |date=2001 |pmid=11669225 |doi=10.1080/00365540110026764 |url=}}</ref>.


==References==
==References==

Latest revision as of 21:52, 22 August 2020

non-bacterial thrombotic endocarditis

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating non-bacterial thrombotic endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-bacterial thrombotic endocarditis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-bacterial thrombotic endocarditis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-bacterial thrombotic endocarditis laboratory findings

CDC on Non-bacterial thrombotic endocarditis laboratory findings

Non-bacterial thrombotic endocarditis laboratory findings in the news

Blogs on Non-bacterial thrombotic endocarditis laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Non-bacterial thrombotic endocarditis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]

Overview

There are no specific diagnostic laboratory findings associated with non-bacterial thrombotic endocarditis. Tests are usually conducted to detect the underlying cause of NBTE and differentiate it from infective endocarditis;.

Laboratory Findings

Hematological and coagulation studies

Blood cultures

Immunological assays[2][3]

Inflammatory markers

The following inflammatory markers are often elevated

Polymerase chain reaction (PCR)

  • PCR is a rapid and reliable method to detect the culture-negative endocarditis by fastidious organisms[4][5].

References

  1. "Libman-Sacks Endocarditis Clinical Presentation: History, Physical Examination".
  2. Hojnik M, George J, Ziporen L, Shoenfeld Y (April 1996). "Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome". Circulation. 93 (8): 1579–87. doi:10.1161/01.cir.93.8.1579. PMID 8608627.
  3. Cervera R (2004). "Coronary and valvular syndromes and antiphospholipid antibodies". Thromb. Res. 114 (5–6): 501–7. doi:10.1016/j.thromres.2004.06.026. PMID 15507284.
  4. Prendergast BD (June 2004). "Diagnostic criteria and problems in infective endocarditis". Heart. 90 (6): 611–3. doi:10.1136/hrt.2003.029850. PMC 1768277. PMID 15145855.
  5. Millar B, Moore J, Mallon P, Xu J, Crowe M, Mcclurg R, Raoult D, Earle J, Hone R, Murphy P (2001). "Molecular diagnosis of infective endocarditis--a new Duke's criterion". Scand. J. Infect. Dis. 33 (9): 673–80. doi:10.1080/00365540110026764. PMID 11669225.

Template:WH Template:WS